A detailed history of Kanawha Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Kanawha Capital Management LLC holds 918 shares of AMGN stock, worth $270,378. This represents 0.02% of its overall portfolio holdings.

Number of Shares
918
Previous 891 3.03%
Holding current value
$270,378
Previous $278,000 6.12%
% of portfolio
0.02%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$309.38 - $337.38 $8,353 - $9,109
27 Added 3.03%
918 $295,000
Q2 2024

Jul 25, 2024

SELL
$262.75 - $319.31 $210,200 - $255,448
-800 Reduced 47.31%
891 $278,000
Q1 2024

Apr 29, 2024

BUY
$268.87 - $324.56 $215,096 - $259,648
800 Added 89.79%
1,691 $480,000
Q3 2023

Oct 26, 2023

BUY
$218.65 - $271.46 $194,817 - $241,870
891 New
891 $239,000
Q1 2023

May 08, 2023

SELL
$225.79 - $275.2 $137,731 - $167,872
-610 Reduced 40.8%
885 $213,000
Q4 2022

Feb 01, 2023

BUY
$229.03 - $291.01 $22,673 - $28,809
99 Added 7.09%
1,495 $393,000
Q3 2022

Oct 31, 2022

BUY
$224.46 - $253.15 $23,568 - $26,580
105 Added 8.13%
1,396 $315,000
Q2 2022

Jul 27, 2022

BUY
$230.71 - $256.74 $1,614 - $1,797
7 Added 0.55%
1,291 $314,000
Q1 2022

Apr 26, 2022

BUY
$219.27 - $242.57 $2,192 - $2,425
10 Added 0.78%
1,284 $310,000
Q4 2021

Jan 31, 2022

SELL
$198.88 - $227.6 $9,944 - $11,380
-50 Reduced 3.78%
1,274 $287,000
Q3 2021

Oct 28, 2021

BUY
$212.27 - $248.7 $212 - $248
1 Added 0.08%
1,324 $282,000
Q1 2021

Apr 26, 2021

BUY
$221.91 - $258.6 $665 - $775
3 Added 0.23%
1,323 $329,000
Q4 2020

Feb 01, 2021

SELL
$216.38 - $257.67 $19,690 - $23,447
-91 Reduced 6.45%
1,320 $303,000
Q3 2020

Oct 29, 2020

BUY
$234.65 - $260.95 $8,447 - $9,394
36 Added 2.62%
1,411 $359,000
Q1 2020

May 04, 2020

BUY
$182.24 - $241.7 $31,345 - $41,572
172 Added 14.3%
1,375 $279,000
Q4 2019

Jan 31, 2020

BUY
$189.21 - $243.2 $227,619 - $292,569
1,203 New
1,203 $290,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Kanawha Capital Management LLC Portfolio

Follow Kanawha Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kanawha Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kanawha Capital Management LLC with notifications on news.